Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Moreover, selective c-Met inhibitors are superior to non-selective c-Met inhibitors in the treatment of liver cancer due to their low toxicity
Motil (2017) 29
Long-term use without regulation has prompted concerns over strain on the kidneys and liver, particularly in those with existing conditions. Dr Rajamanya added: Very little of the oral form of glutathione enters the system because it has relatively low bioavailability
Advance in antitumor agents targeting glutathione-S-transferase [PMID: 16719788] Laboratory literature summary: Advance in antitumor agents targeting glutathione-S-transferase
US$ 25.95
US$ 29.03
US$ 26.87
